Cost-Effectiveness of Paclitaxel, Doxorubicin, Cyclophosphamide and Trastuzumab Versus Docetaxel, Cisplatin and Trastuzumab in New Adjuvant Therapy of Breast Cancer in China.
Research Square (Research Square)